The Pharmacology and Toxicology category covers a wide range of topics and this section strives to reflect that diversity. The section will emphasize original work and mini reviews that elucidate drug action and underlying mechanisms, new druggable targets, or unusual drug responses (e.g., due to polymorphisms and drug interactions), which contribute significant knowledge to pharmacology or toxicology. Submissions are expected to meet the standards of pharmacological and/or toxicological investigation. For example, manuscripts should include dose-response analysis, rather than using a single dose, and seek to demonstrate cause and effect relationships, rather than only presenting correlational findings. Appropriate control groups, such as drug vehicle-treated and drug-exposed normal groups, should be included. While manuscripts in all areas of pharmacology and toxicology are welcomed, studies on herbal medicines or plant extracts with unknown components or mixtures of active ingredients are generally not appropriate unless exceptional new activity has been discovered. Manuscripts reporting a known drug action on previously unstudied cells or tissue are generally also not appropriate without strong justification of the importance of the study.
Santosh Kumar, University of Tennessee Health Science Center
Matthias Barton, MD, University of Zurich, Switzerland
Guzel Bikbova, MD/PhD, Chiba University, Japan
Pawel Brzuzan, PhD, University of Warmia and Mazury in Olsztyn, Poland
Laetitia Dou, PhD, Aix-Marseille Universite, France
Jianxiong Jiang, PhD, University of Tennessee Health Science Center, USA
Youngmi Jung, PhD, Pusan National University, Korea
Li-Fu Li, MD/PhD, Chang Gung Memorial Hospital and Chang Gung University, Taiwan
Samuel Gnana Prakash Vincent, PhD, Manonmaniam Sundaranar University, India
Jonathan Henry Shannahan, PhD, Purdue University, USA
Martin Sterba, PhD, Charles University Faculty of Medicine in Hradec Kralove,Czech Republic
Manish K. Tripathi, University of Texas Rio Grande Valley
Chaowu Xiao, PhD, Health Canada, Canada
Wuxiang Xie, PhD, Peking University Clinical Research Institute, China
Qihe Xu, MD/PhD, Kings College London, UK
Advisory board and editorial team
SEBM’s Publications Committee and EBM’s Editorial Board provides strategic and professional advice to the Editor-in-Chief, Dr Steven Goodman. The journal recognises the following Editorial Board members for their continuous guidance and support of the journal:
Steven R. Goodman, PhD, University of Tennessee Health Science Center, Memphis, TN, USA
Assistant to the Editor-in-Chief
Benjamin Zimmer, Society for Experimental Biology and Medicine, Washington D.C., USA
Gordon Awandare, PhD, University of Ghana, Africa
Shaw-Jeng Tsai, PhD, National Cheng-Kung University Medical College, Taiwan
Latin America Editor
Nicola Conran, PhD, University of Campinas, Brazil
Farzin Farzaneh, PhD, King's College London, UK
Dr. Sulev Koks, Murdoch University, Perth, Australia
The full editor list for EBM can be found here.
Exp. biol. med.
3.2 Impact Factor
Experimental Biology and Medicine is composed of the following categories:
When submitting a manuscript to Experimental Biology and Medicine, authors must submit the material directly to one of the categories. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective category.
Open access statement
EBM provides online free gold open access to the journal and all of its research publications.
Open Access funder and institutional mandates: EBM is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution license (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in EBM. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.
Under the Conditions for Website Use and the General Conditions for Authors, authors of articles published in EBM retain copyright on their articles, except for any third-party images and other materials added by EBM, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. Visitors may also download and forward articles subject to the citation requirements and subject to any fees EBM’s publisher, Frontiers, may charge for downloading licenses. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially.
Each EBM article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. EBM encourages authors to consult the instructions for authors guidelines prior to submission.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For queries regarding thematic issues, fee support, and any other questions, please contact email@example.com
For all queries regarding manuscripts in review or potential conflicts of interest, please contact firstname.lastname@example.org
EBM Editorial Offices
For any additional questions or queries, please contact email@example.com
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our HelpDesk, or contact our IT HelpDesk team at firstname.lastname@example.org